Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in Tanzania: prevalence and predictors

Key Points

• Steatotic liver disease prevalence is notably high among patients with type 2 diabetes in Tanzania.
• Key predictors include metabolic dysfunction parameters such as BMI and blood glucose levels.
• Observational analysis across various healthcare facilities in Tanzania highlights the urgent need for awareness and screening.
• Findings support the notion that metabolic health is crucial for preventing liver disease in diabetes patients.